Hiscox Ltd (LON:HSX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six analysts that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is GBX 1,466.83.
A number of research analysts recently commented on the company. The Goldman Sachs Group increased their price target on Hiscox from GBX 1,560 to GBX 1,713 and gave the company a "buy" rating in a report on Wednesday, January 21st. Jefferies Financial Group lifted their price objective on Hiscox from GBX 1,068 to GBX 1,148 and gave the stock an "underperform" rating in a report on Thursday, March 5th.
Check Out Our Latest Report on HSX
Hiscox Price Performance
Shares of Hiscox stock opened at GBX 1,558 on Monday. The business has a 50-day moving average of GBX 1,497.83 and a 200-day moving average of GBX 1,419.69. The company has a market capitalization of £5.04 billion, a PE ratio of 8.90, a P/E/G ratio of -2.30 and a beta of 0.37. Hiscox has a 1-year low of GBX 1,037 and a 1-year high of GBX 1,566.
About Hiscox
(
Get Free Report)
Hiscox is a global, specialty insurer, listed on the London Stock Exchange and headquartered in Bermuda. We have grown from
our roots as a niche Lloyd's of London underwriter into a diversified international insurance group operating across direct‑to‑consumer, broker and partner‑distributed retail insurance; large and complex commercial insurance; reinsurance and insurance‑linked strategies.
We currently employ over 3,000 people worldwide across 13 countries and 31 offices. We have a distinctive brand, energised and ambitious teams, a strong balance sheet, and plenty of room to grow in each of our chosen markets and lines of business.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hiscox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hiscox wasn't on the list.
While Hiscox currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.